The Experts below are selected from a list of 45 Experts worldwide ranked by ideXlab platform
Scott T Weiss - One of the best experts on this subject based on the ideXlab platform.
-
real world evaluation of asthma control and treatment react findings from a national web based survey
The Journal of Allergy and Clinical Immunology, 2007Co-Authors: Stephen P Peters, Craig A Jones, Tmirah Haselkorn, David R Mink, David J Valacer, Scott T WeissAbstract:Background Despite health initiatives for advancing the management of asthma, evidence suggests that many asthmatic subjects have uncontrolled disease. However, the prevalence of uncontrolled asthma in the United States is not known and has not been fully characterized. Objective We sought to assess the prevalence, morbidity, and factors associated with uncontrolled asthma in a nationally representative sample of patients with moderate-to-severe asthma using standard asthma medications. Methods A Web-based survey was administered to patients with diagnoses of asthma for at least 1 year who were receiving Multiple Controller medications. The Asthma Control Test score was used to stratify respondents into controlled and uncontrolled cohorts. Results A total of 1812 patients were assessed; 809 (45%) had controlled asthma, and 1003 (55%) had uncontrolled asthma. Most patients had health care coverage and received care from a general practitioner; a large proportion of patients with controlled asthma (74%) and patients with uncontrolled asthma (65%) reported never receiving an asthma action plan. Inhaled corticosteroid plus long-acting β-agonist was the most common medication regimen in patients with controlled asthma (60%) and patients with uncontrolled asthma (48%) patients. Patients with uncontrolled asthma reported significantly higher rates of health care use. Several comorbidities were predictive of uncontrolled asthma. Conclusion Uncontrolled asthma is highly prevalent (55%) in patients using standard asthma medications. There is need for improved asthma care in patients with moderate-to-severe asthma, including a global evaluation of asthma control, implementation of treatment plans and asthma control tests, and addressing comorbid conditions. Clinical implications Improved asthma care requires broader assessments of asthma control, including asthma-related health care and medication use, comorbidities, and the implementation of treatment plans and formal asthma control tests.
Stephen P Peters - One of the best experts on this subject based on the ideXlab platform.
-
real world evaluation of asthma control and treatment react findings from a national web based survey
The Journal of Allergy and Clinical Immunology, 2007Co-Authors: Stephen P Peters, Craig A Jones, Tmirah Haselkorn, David R Mink, David J Valacer, Scott T WeissAbstract:Background Despite health initiatives for advancing the management of asthma, evidence suggests that many asthmatic subjects have uncontrolled disease. However, the prevalence of uncontrolled asthma in the United States is not known and has not been fully characterized. Objective We sought to assess the prevalence, morbidity, and factors associated with uncontrolled asthma in a nationally representative sample of patients with moderate-to-severe asthma using standard asthma medications. Methods A Web-based survey was administered to patients with diagnoses of asthma for at least 1 year who were receiving Multiple Controller medications. The Asthma Control Test score was used to stratify respondents into controlled and uncontrolled cohorts. Results A total of 1812 patients were assessed; 809 (45%) had controlled asthma, and 1003 (55%) had uncontrolled asthma. Most patients had health care coverage and received care from a general practitioner; a large proportion of patients with controlled asthma (74%) and patients with uncontrolled asthma (65%) reported never receiving an asthma action plan. Inhaled corticosteroid plus long-acting β-agonist was the most common medication regimen in patients with controlled asthma (60%) and patients with uncontrolled asthma (48%) patients. Patients with uncontrolled asthma reported significantly higher rates of health care use. Several comorbidities were predictive of uncontrolled asthma. Conclusion Uncontrolled asthma is highly prevalent (55%) in patients using standard asthma medications. There is need for improved asthma care in patients with moderate-to-severe asthma, including a global evaluation of asthma control, implementation of treatment plans and asthma control tests, and addressing comorbid conditions. Clinical implications Improved asthma care requires broader assessments of asthma control, including asthma-related health care and medication use, comorbidities, and the implementation of treatment plans and formal asthma control tests.
Nor Badrul Anuar - One of the best experts on this subject based on the ideXlab platform.
-
Cost Effective Network Flow Measurement for Software Defined Networks: A Distributed Controller Scenario
IEEE Access, 2018Co-Authors: Hamid Tahaei, Rosli Bin Salleh, Mohd Faizal Ab Razak, Nor Badrul AnuarAbstract:Software-defined networking (SDN) has emerged as an evolutionary paradigm in datacenter networks by separating data from control plane and centralizing network decision making. Traffic flow measurement in SDN is relatively lightweight in comparison to the traditional methods. It enables flow measurement system to overcome the issues of traditional measurement systems, such as cost and accuracy by employing a centralized Controller. Nevertheless, a full physically centralized Controller introduces negative impacts on the network as well as the measurement system (i.e., introducing extra overhead or accuracy issues). However, few efforts have been devoted to measurement techniques in SDN distributed Controller architecture, where every Controller pulls its corresponding flow statistics, and these statistics are required to expose by only one single expression as if they are collected by one Controller. Moreover, the imposed costs of flow measurement in distributed Controller architecture are still an issue that remains unsolved. In this paper, we attempt to fill in this gap and present a novel and a practical solution for a cost-effective measurement system in SDN distributed Controller deployment. We also propose a synchronization mechanism for aggregating traffic statistics in the Multiple Controller model. We evaluate our method through extensive emulations in a datacenter topology and present our findings to demonstrate the impact of Multiple Controllers on overhead and accuracy.
Craig A Jones - One of the best experts on this subject based on the ideXlab platform.
-
real world evaluation of asthma control and treatment react findings from a national web based survey
The Journal of Allergy and Clinical Immunology, 2007Co-Authors: Stephen P Peters, Craig A Jones, Tmirah Haselkorn, David R Mink, David J Valacer, Scott T WeissAbstract:Background Despite health initiatives for advancing the management of asthma, evidence suggests that many asthmatic subjects have uncontrolled disease. However, the prevalence of uncontrolled asthma in the United States is not known and has not been fully characterized. Objective We sought to assess the prevalence, morbidity, and factors associated with uncontrolled asthma in a nationally representative sample of patients with moderate-to-severe asthma using standard asthma medications. Methods A Web-based survey was administered to patients with diagnoses of asthma for at least 1 year who were receiving Multiple Controller medications. The Asthma Control Test score was used to stratify respondents into controlled and uncontrolled cohorts. Results A total of 1812 patients were assessed; 809 (45%) had controlled asthma, and 1003 (55%) had uncontrolled asthma. Most patients had health care coverage and received care from a general practitioner; a large proportion of patients with controlled asthma (74%) and patients with uncontrolled asthma (65%) reported never receiving an asthma action plan. Inhaled corticosteroid plus long-acting β-agonist was the most common medication regimen in patients with controlled asthma (60%) and patients with uncontrolled asthma (48%) patients. Patients with uncontrolled asthma reported significantly higher rates of health care use. Several comorbidities were predictive of uncontrolled asthma. Conclusion Uncontrolled asthma is highly prevalent (55%) in patients using standard asthma medications. There is need for improved asthma care in patients with moderate-to-severe asthma, including a global evaluation of asthma control, implementation of treatment plans and asthma control tests, and addressing comorbid conditions. Clinical implications Improved asthma care requires broader assessments of asthma control, including asthma-related health care and medication use, comorbidities, and the implementation of treatment plans and formal asthma control tests.
David J Valacer - One of the best experts on this subject based on the ideXlab platform.
-
real world evaluation of asthma control and treatment react findings from a national web based survey
The Journal of Allergy and Clinical Immunology, 2007Co-Authors: Stephen P Peters, Craig A Jones, Tmirah Haselkorn, David R Mink, David J Valacer, Scott T WeissAbstract:Background Despite health initiatives for advancing the management of asthma, evidence suggests that many asthmatic subjects have uncontrolled disease. However, the prevalence of uncontrolled asthma in the United States is not known and has not been fully characterized. Objective We sought to assess the prevalence, morbidity, and factors associated with uncontrolled asthma in a nationally representative sample of patients with moderate-to-severe asthma using standard asthma medications. Methods A Web-based survey was administered to patients with diagnoses of asthma for at least 1 year who were receiving Multiple Controller medications. The Asthma Control Test score was used to stratify respondents into controlled and uncontrolled cohorts. Results A total of 1812 patients were assessed; 809 (45%) had controlled asthma, and 1003 (55%) had uncontrolled asthma. Most patients had health care coverage and received care from a general practitioner; a large proportion of patients with controlled asthma (74%) and patients with uncontrolled asthma (65%) reported never receiving an asthma action plan. Inhaled corticosteroid plus long-acting β-agonist was the most common medication regimen in patients with controlled asthma (60%) and patients with uncontrolled asthma (48%) patients. Patients with uncontrolled asthma reported significantly higher rates of health care use. Several comorbidities were predictive of uncontrolled asthma. Conclusion Uncontrolled asthma is highly prevalent (55%) in patients using standard asthma medications. There is need for improved asthma care in patients with moderate-to-severe asthma, including a global evaluation of asthma control, implementation of treatment plans and asthma control tests, and addressing comorbid conditions. Clinical implications Improved asthma care requires broader assessments of asthma control, including asthma-related health care and medication use, comorbidities, and the implementation of treatment plans and formal asthma control tests.